AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea flag South Korea · Delayed Price · Currency is KRW
64,300
+1,100 (1.74%)
At close: Apr 28, 2026

AprilBio Revenue

In the year 2025, AprilBio had annual revenue of 2.17B KRW, down -92.11%.

Revenue
2.17B
Revenue Growth
-92.11%
P/S Ratio
691.04
Revenue / Employee
n/a
Employees
n/a
Market Cap
1,500.93B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20252.17B-25.34B-92.11%
Dec 31, 202427.51B--
Dec 31, 2023---
Dec 31, 2022200.00M-23.20B-99.15%
Dec 31, 202123.40B--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ROKIT Healthcare 26.25B
JS Link 19.32B
Qurient 6.98B
Inventage Lab 2.94B
Aimed Bio 47.28B
IntoCell 2.30B
HansBiomed 100.17B
Revenue Rankings